YOLFTbeta
30

GKHT Medical Technology Co. Ltd. A

301370 · SHE · Healthcare / Medical Distribution

7.91CNY-0.15 (-1.86%)

Price History

Full chart

Market Stats

Previous Close8.06
Open8.06
Day Range7.89 – 8.08
52-Week Range7.89 – 12.95
Volume1.93M
Market Cap4.11B
P/E (TTM)174.80
Forward P/E0.00
EPS0.05
Dividend Yield1.40%
Beta0.26
50-Day Avg8.71
200-Day Avg10.04

About

GKHT Medical Technology Co., Ltd. distributes and sells medical devices in China. The company offers vascular interventional therapy materials, orthopedic materials, neurosurgical materials, non-vascular interventional therapy materials, and dental materials. It also provides logistics and distribution services, as well as information products and services for medical devices. The company was founded in 2013 and is based in Beijing, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMs. Wei Xiao
  • Employees873
  • HeadquartersRoom 501C, Building 6, Beijing, China, 100176, China
  • Websitehttps://www.gkht.com

Leadership

  • Ms. Wei XiaoGM & Director · b. 1982
  • Mr. Jinhong WuDeputy GM, CFO, Head of Accounting Department & Accounting Supervisor · b. 1979
  • Ms. Xiaobei WangDeputy GM, Board Secretary & Director · b. 1978
  • Mr. Haipeng FeiDeputy General Manager · b. 1975
  • Mr. Wei LuDeputy General Manager · b. 1976
  • Mr. Hua LuoDeputy General Manager · b. 1974

Financials

Income Statement

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue5.85B6.36B7.48B7.35B6.99B
Growth (%)-+8.76%+17.66%-1.82%-4.89%
Cost of Revenue5.02B5.52B6.60B6.56B6.25B
Gross Profit826.68M840.47M878.98M791.28M741.85M
Gross Margin14.14%13.22%11.75%10.77%10.62%
Operating Expense407.29M470.40M540.77M539.40M529.34M
Operating Income419.40M370.07M338.21M251.89M212.51M
Operating Margin7.17%5.82%4.52%3.43%3.04%
EBITDA-636.05M426.85M362.01M223.99M
EBITDA Margin-10.00%5.70%4.93%3.21%
Net Income151.21M124.91M153.88M130.66M68.15M
Net Income Margin2.59%1.96%2.06%1.78%0.98%
R&D10.55M12.40M12.90M10.95M10.35M
R&D as % of Total Revenue0.18%0.20%0.17%0.15%0.15%
Interest Expense128.96M238.63M88.18M60.95M34.35M
Interest Expense % of Total Revenue2.21%3.75%1.18%0.83%0.49%

Balance Sheet

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets6.74B7.31B7.04B6.64B6.34B
Total Liabilities5.28B5.75B4.49B4.07B3.79B
Total Equity1.33B1.45B2.45B2.48B2.51B
Cash354.08M624.90M507.85M695.04M731.15M
Net Debt2.03B1.99B714.72M671.10M288.36M

Cash Flow

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow284.48M481.24M717.20M649.14M678.31M
Capital Expenditure138.70M267.14M154.83M42.82M32.26M
Free Cash Flow145.78M214.10M562.37M606.32M646.05M
Dividends Paid128.78M122.02M99.58M110.56M67.25M
FCF to OCF51.24%44.49%78.41%93.40%95.24%
Dividend Paid to FCF88.34%56.99%17.71%18.23%10.41%

Earnings

Report DateSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------
EPS Actual0.050.130.060.080.080.07-0.020.130.030.000.000.02
Surprise------------
Timing------------

Key Statistics & Ratios

Market Cap4.11B
Enterprise Value4.87B
Trailing P/E174.80
Forward P/E0.00
Price / Sales0.64
Price / Book1.65
EPS0.05
Book Value5.27
Revenue (TTM)6.47B
Gross Profit (TTM)579.71M
EBITDA85.42M
Profit Margin0.41%
Operating Margin-0.12%
Return on Equity0.65%
Return on Assets0.61%
Shares Outstanding470.60M
Shares Float229.11M
Beta0.26
Dividend Yield1.40%
Dividend Rate0.12
Payout Ratio2.13%

Dividends

20261×
0.12Jun 17, 2026
20251×
0.08May 29, 2025
20241×
0.12Aug 9, 2024